DSIJ Mindshare

The drama and farce of ‘no-confidence

Prakash Patil 0 1125 Article rating: 5.0

The people of India do not need such dramatized versions of performance evaluation by the opposition parties or by the government.  They live and experience the performance or non-performance of the government on a daily basis, so they will deliver their verdict as per their own parameters of performance assessment and according to their own political judgement. 

Jubilant Life Sciences' subsidiary to initiate clinical trial to treat neuroblastoma

Shohini Nath 0 2090 Article rating: 5.0

Jubilant Life Sciences has announced that its subsidiary Jubilant Pharma Limited has initiated Optimum trial, which is a pivotal Phase II clinical trial, designed to prove the safety and effectiveness of I-131 MIBG for the treatment of neuroblastoma. This will be taking place through Jubilant Pharma's unit Jubilant DraxImage Inc. in Montreal, Canada.

 

Ceat Tyres rolls up post Q1 results, stock gives range breakout

Bhagyashree Vivarekar 0 1418 Article rating: 5.0

Auto Tyres and rubber tubes company, Ceat surged as much as 9.5 per cent in Friday’s trade on reporting Q1FY19 results. On Friday, the stock bounced back very sharply, breaching its two prior resistances at 1327 followed by 1351, supported by spurt in volumes and 14-period RSI crossing 55 levels.

RSS
First56085609561056115613561556165617Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR